These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 6245359

  • 1. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia.
    Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL.
    N Engl J Med; 1980 May 08; 302(19):1041-6. PubMed ID: 6245359
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
    Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, Emanuel D, Laver J, O'Reilly RJ.
    N Engl J Med; 1987 Dec 24; 317(26):1618-24. PubMed ID: 3317056
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul 24; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 4. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
    Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H.
    N Engl J Med; 1983 Dec 01; 309(22):1347-53. PubMed ID: 6355849
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P.
    Cancer J Sci Am; 1996 Dec 01; 2(6):330-4. PubMed ID: 9166553
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B, Weisdorf DJ, Kim T, Kersey JH, Ramsay NK.
    Bone Marrow Transplant; 1990 Feb 01; 5(2):83-9. PubMed ID: 2107007
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic bone marrow transplantation.
    Weiden PL.
    Crit Rev Clin Lab Sci; 1983 Feb 01; 19(3):173-86. PubMed ID: 6373140
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic marrow grafting for acute leukemia: a follow-up of long-term survivors.
    Stewart PS, Buckner CD, Clift RA, Sanders JE, Storb R, Leonard JM, Thomas ED.
    Exp Hematol; 1979 Nov 01; 7(10):509-18. PubMed ID: 44872
    [Abstract] [Full Text] [Related]

  • 9. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May 01; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N.
    Bone Marrow Transplant; 1997 Oct 01; 20(7):533-41. PubMed ID: 9337054
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S.
    Bone Marrow Transplant; 1996 Oct 01; 18(4):741-6. PubMed ID: 8899189
    [Abstract] [Full Text] [Related]

  • 12. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.
    Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R.
    N Engl J Med; 1979 May 10; 300(19):1068-73. PubMed ID: 34792
    [Abstract] [Full Text] [Related]

  • 13. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience.
    Inoue T, Masaoka T, Shibata H.
    Strahlenther Onkol; 1986 Jun 10; 162(6):368-73. PubMed ID: 3526600
    [Abstract] [Full Text] [Related]

  • 14. Successful allogeneic bone marrow transplantation for three children with acute nonlymphocytic leukemia.
    Ohira M, Takayama J, Hanada M.
    Jpn J Clin Oncol; 1984 Dec 10; 14 Suppl 1():487-93. PubMed ID: 6097709
    [Abstract] [Full Text] [Related]

  • 15. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
    Blau IW, Basara N, Bischoff M, Günzelmann S, Römer E, Kirsten D, Schmetzer B, Kiehl MG, Fauser AA.
    Bone Marrow Transplant; 2000 Jan 10; 25(1):41-5. PubMed ID: 10654013
    [Abstract] [Full Text] [Related]

  • 16. [Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
    Schmitz N, Kayser W, Gassmann W, Euler HH, Wüstemann M, Brix F, Dühmke E, Hebbinghaus D, Gremmel H, Schaub J.
    Dtsch Med Wochenschr; 1985 Sep 27; 110(39):1488-93. PubMed ID: 3896727
    [Abstract] [Full Text] [Related]

  • 17. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
    Kersey JH, Weisdorf D, Nesbit ME, LeBien TW, Woods WG, McGlave PB, Kim T, Vallera DA, Goldman AI, Bostrom B.
    N Engl J Med; 1987 Aug 20; 317(8):461-7. PubMed ID: 3302708
    [Abstract] [Full Text] [Related]

  • 18. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP.
    N Engl J Med; 1999 Jul 01; 341(1):14-21. PubMed ID: 10387937
    [Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP, Doria R, Khan K, Zelterman D, Ahmad YH, Smith BR, Holmes W, Becker P, Roberts KB, Rappeport JM.
    Bone Marrow Transplant; 1999 Jun 01; 23(11):1095-100. PubMed ID: 10382947
    [Abstract] [Full Text] [Related]

  • 20. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR, Berger C, Kröger N, Stockshläder M, Krüger W, Horstmann M, Grimm J, Zeller W, Kabisch H, Erttmann R, Schönrock P, Kuse R, Braumann D, Illiger HJ, Fiedler W, de Witt M, Hossfeld KD, Weh HJ.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.